The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

ARIAD to Webcast Conference Call on First Quarter 2012 Financial Results

Wednesday, April 25, 2012

ARIAD to Webcast Conference Call on First Quarter 2012 Financial Results07:35 EDT Wednesday, April 25, 2012 CAMBRIDGE, Mass. (Business Wire) -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will host a live webcast of its quarterly conference call at 8:30 a.m. (ET) on Wednesday, May 9, 2012. Harvey J. Berger, M.D., chairman and chief executive officer, will host the call. ARIAD senior management will discuss the Company's financial results as of March, 31, 2012, as well as key corporate objectives and additional corporate activities. The Company will announce highlights of these topics in a press release to be issued before the market opens on May 9, 2012 prior to the conference call. The live webcast can be accessed by visiting the investor relations section of the Company's website at The call can be accessed by dialing 800-260-8140 (domestic) or 617 -614-3672 (international) five minutes prior to the start time and providing the pass code 33704570. A replay of the call will be available on the ARIAD website approximately two hours after completion of the call and will be archived for three weeks. About ARIAD ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD's approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant or difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. For additional information, visit or follow ARIAD on Twitter. ARIAD Pharmaceuticals, Inc.For InvestorsMaria E. Cantor, (617) 621-2208Maria.cantor@ariad.comorFor MediaLynn Granito, (212)